Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis. (17th May 2021)
- Record Type:
- Journal Article
- Title:
- Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis. (17th May 2021)
- Main Title:
- Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis
- Authors:
- Ortega, Juliana Festa
Heidor, Renato
Auriemo, Ana Paula
Marques Affonso, Juliana
Pereira D' Amico, Thais
Herz, Corinna
de Conti, Aline
Ract, Juliana
Gioieli, Luiz Antônio
Purgatto, Eduardo
Lamy, Evelyn
P. Pogribny, Igor
Salvador Moreno, Fernando - Abstract:
- Abstract: Hepatocellular carcinoma (HCC) presents with a high treatment resistance and poor prognosis. Early diagnosis and preventive approaches such as chemoprevention are essential for the HCC control. Therefore, we evaluated the chemopreventive effects of butyrate-containing structured lipids (STLs) administered during the promotion stage of hepatocarcinogenesis in rats submitted to the 'resistant hepatocyte' (RH) model. Administration of butyrate-containing STLs inhibited the incidence and mean number of visible hepatic nodules per rat and reduced the number and area of glutathione S -transferase placental form-positive (GST-P + ) preneoplastic focal lesions in the livers. This was accompanied by the induction of apoptosis and an increased level of hepatic butyric acid. Treatment with butyrate-containing STLs resulted in increased histone H3 lysine 9 (H3K9) acetylation, reduction of total histone deacetylase (HDAC) activity, and lower levels of HDAC4 and HDAC6 proteins. The chemopreventive effect of butyrate-containing STLs was also associated with the increased nuclear compartmentalization of p53 protein and reduced expression of the Bcl-2 protein. In addition, rats treated with butyrate-containing STLs showed decreased DNA damage and telomerase activity in the livers. These results demonstrate that the suppressive activity of butyrate-containing STLs is associated with inhibition of elevated during hepatocarcinogenesis chromatin-modifying proteins HDAC4 and HDAC6,Abstract: Hepatocellular carcinoma (HCC) presents with a high treatment resistance and poor prognosis. Early diagnosis and preventive approaches such as chemoprevention are essential for the HCC control. Therefore, we evaluated the chemopreventive effects of butyrate-containing structured lipids (STLs) administered during the promotion stage of hepatocarcinogenesis in rats submitted to the 'resistant hepatocyte' (RH) model. Administration of butyrate-containing STLs inhibited the incidence and mean number of visible hepatic nodules per rat and reduced the number and area of glutathione S -transferase placental form-positive (GST-P + ) preneoplastic focal lesions in the livers. This was accompanied by the induction of apoptosis and an increased level of hepatic butyric acid. Treatment with butyrate-containing STLs resulted in increased histone H3 lysine 9 (H3K9) acetylation, reduction of total histone deacetylase (HDAC) activity, and lower levels of HDAC4 and HDAC6 proteins. The chemopreventive effect of butyrate-containing STLs was also associated with the increased nuclear compartmentalization of p53 protein and reduced expression of the Bcl-2 protein. In addition, rats treated with butyrate-containing STLs showed decreased DNA damage and telomerase activity in the livers. These results demonstrate that the suppressive activity of butyrate-containing STLs is associated with inhibition of elevated during hepatocarcinogenesis chromatin-modifying proteins HDAC4 and HDAC6, subcellular redistribution of the p53 protein, and decreased DNA damage and telomerase activity. Abstract : The chemopreventive effects of butyrate-containing structured lipids during the promotion stage of hepatocarcinogenesis in rats are associated with the inhibition of chromatin-modifying proteins HDAC4 and HDAC6 elevated during hepatocarcinogenesis, subcellular redistribution of the p53 protein, and decreased DNA damage and telomerase activity. … (more)
- Is Part Of:
- Carcinogenesis. Volume 42:Number 8(2021)
- Journal:
- Carcinogenesis
- Issue:
- Volume 42:Number 8(2021)
- Issue Display:
- Volume 42, Issue 8 (2021)
- Year:
- 2021
- Volume:
- 42
- Issue:
- 8
- Issue Sort Value:
- 2021-0042-0008-0000
- Page Start:
- 1026
- Page End:
- 1036
- Publication Date:
- 2021-05-17
- Subjects:
- Carcinogenesis -- Periodicals
Cancer -- Genetic aspects -- Periodicals
Cancer -- Prevention -- Periodicals
Cancer -- Periodicals
616.994071 - Journal URLs:
- http://carcin.oupjournals.org ↗
http://carcin.oxfordjournals.org ↗
http://www.ingenta.com/journals/browse/oup/carcin?mode=direct ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1093/carcin/bgab039 ↗
- Languages:
- English
- ISSNs:
- 0143-3334
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3051.007000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25624.xml